Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma
American Society of Clinical OncologyPublished: February 10, 2025
- Key Points
- Management
- Baseline Assessment for TORS Candidacy
- Goals of TORS in Patients With HPV-Positive OPC
- Patients With Resected HPV-Positive OPC That Should be Considered for Adjuvant Therapy
- The Role of TORS in HPV-Negative OPC Patient Populations
- Role of TORS in Salvage/Recurrent Setting in Both HPV-Positive and HPV-Negative OPC
- Figures and Algorithms
- Evaluation and Workup
- Decision Making on the Use of TORS
- Post-Operative Management
Also Found In
You rely on Guideline Central for transparency
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.